RZRui Zhou

Rui Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rui Zhou has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Guanghui Yang

    State Key Laboratory of Membrane Biology, School of Life Sciences and School of Medicine, Tsinghua University, Beijing, China

    1 shared publication
  • Guanghui Yang

    Beijing Advanced Innovation Center for Structural Biology, Tsinghua University, Beijing 100084, China;

    1 shared publication
  • Yigong Shi

    Research Center for Industries of the Future, Center for Infectious Disease Research, Zhejiang Key Laboratory of Structural Biology, State Key Laboratory of Gene Expression, School of Life Sciences, Westlake University, Hangzhou, China

    1 shared publication
  • Yigong Shi

    Beijing Advanced Innovation Center for Structural Biology & Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Beijing 100084, China; School of Life Sciences, Westlake University, 18 Shilongshan Road, Xihu District, Hangzhou 310024, Zhejiang Province, China

    1 shared publication

Latest Publications

  • Open Access

    Dominant negative effect of the loss-of-function γ-secretase mutants on the wild-type enzyme through heterooligomerization

    by Rui Zhou, Guanghui Yang, Yigong Shi

    γ-secretase is an intramembrane protease complex consisting of nicastrin, presenilin-1/2, APH-1a/b, and Pen-2. Hydrolysis of the 99-residue transmembrane fragment of amyloid precursor protein (APP-C99) by γ-secretase produces β-amyloid (Aβ) peptides. Pathogenic mutations in PSEN1 and PSEN2, which encode the catalytic subunit presenilin-1/2 of γ-secretase, lead to familial Alzheimer’s disease in an autosomal dominant manner. However, the underlying mechanism of how the mutant PSEN gene may affect the function of the WT allele remains to be elucidated. Here we report that each of the loss-of-function γ-secretase variants that carries a PSEN1 mutation suppresses the protease activity of the WT γ-secretase on Aβ production. Each of these γ-secretase variants forms a stable oligomer with the WT γ-secretase in vitro in the presence of the detergent CHAPSO {3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate}, but not digitonin. Importantly, robust protease activity of γ-secretase is detectable in the presence of CHAPSO, but not digitonin. These experimental observations suggest a dominant negative effect of the γ-secretase, in which the protease activity of WT γ-secretase is suppressed by the loss-of-function γ-secretase variants through hetero-oligomerization. The relevance of this finding to the genesis of Alzheimer’s disease is critically evaluated. Significance The vast majority of familial Alzheimer’s disease (AD) cases are linked to mutations in presenilin-1 (PS1) in an autosomal dominant manner. PS1 is the catalytic component of γ-secretase, which cleaves amyloid precursor protein into Aβ peptides. It remains unclear whether the causal role of PS1 mutations in AD development is effected through γ-secretase, and if yes, whether the dominant negative effect of PS1 mutant allele is effected through the proteolytic activity of γ-secretase. In this study, we provide compelling evidence to prove a dominant negative effect by the loss-of-function γ-secretase mutants on the production of Aβ42/40 by WT γ-secretase through hetero-oligomerization. These data, together with our prior knowledge on the function of γ-secretase, have important ramifications on the two key questions listed here.